Boston Scientific Corp. is taking nine U.S., Irish, and South Korean companies to task for infringing patents that cover stents and delivery services for treating digestive diseases. The medical device manufacturer filed a complaint Monday in the U.S. District Court for the District of Massachusetts, contending it has suffered damages because of endoscopy products that those companies have made, imported, or sold that bear a close resemblance to its own line of such devices, including the WallFlex stent. The suit accuses Cook, Inc., Wilson-Cook Medical Inc., Cook Medical Inc., Cook Ireland Ltd., Cook Group Inc., Standard Sci-Tech Inc, EndoChoice Inc., Sewoon Medical Co., Ltd. and Taewoong Medical Co. Ltd. of infringing U.S. Patent No. 6,007,574, titled “Stent,” U.S. Patent No. 6,533,810, titled “Conical Stent,” and U.S. Patent No. 6,818,015, also titled “Conical Stent.” Those patents are either owned or licensed to Boston Scientific or its subsidiaries, according to the complaint and Boston Scientific is seeking a judgment that the patents have been infringed as well as unspecified damages. Boston Scientific is represented by Finnegan.
Press Release
October 6, 2026
Award/Ranking
Finnegan Named an IP Litigation Powerhouse in BTI Litigation Outlook 2027
September 24, 2026
Award/Ranking
Finnegan Receives Top Tier Rankings in World Trademark Review’s Inaugural Copyright 1000 2026
September 23, 2026
Press Release
Finnegan Secures Precedential Pro Bono Federal Circuit Victory for AI Whistleblower
September 23, 2026
Commentary
New Thomas Pink Womenswear Lines Strain ‘Pink’ Pact with Victoria’s Secret
September 21, 2026
Commentary
FORUM IP Talks: Dr. Jochen Herr on UPC, FRAND, and Cross-Border Enforcement Topics
September 20, 2026
Commentary
Pepsi's U.S. Trademark Dispute Could Reshape Brand Choices, Lawsuit Strategy, Lawyers Say
September 17, 2026
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.